The rise of Medicare
Advantage signals the transformation of Medicare to a program in which a
majority of people receive benefits by enrolling in plans offered by
private health insurance companies.
The new analysis is one
of three released today by KFF in which researchers examine various
aspects of Medicare Advantage. It provides the latest data on Medicare
Advantage enrollment, including the types of plans in which Medicare
beneficiaries are enrolled, and how enrollment varies across geographic
areas. A companion analysis describes Medicare Advantage premiums,
out-of-pocket limits, cost sharing, extra benefits offered, and prior
authorization requirements. A third examines trends in bonus payments to
Medicare Advantage plans, enrollment in plans in bonus status, and how
these measures vary across plan types and firms.
Among
other key findings:
- Enrollment in
private plans is highly concentrated among a small number of firms,
with UnitedHealthcare and Humana together accounting for 46 percent
of all Medicare Advantage enrollees nationwide. In nearly a third of
counties across the U.S., these two firms account for at least 75
percent of Medicare Advantage enrollment.
- In 2022, nearly 7
in 10 Medicare Advantage enrollees (69%) are in plans with
prescription drug coverage (MA-PDs) that require no premium other
than the Medicare Part B premium ($170.10 in 2022).
- Nearly all
enrollees in individual Medicare Advantage plans open for general
enrollment have access to some benefits not covered by traditional
Medicare, including eye exams and/or glasses (99%), hearing exams
and/or aids (98%), and a fitness benefit (98%).
- Virtually all
Medicare Advantage enrollees (99%) are in plans that require prior
authorization for some services. Prior authorization is most often
required for relatively expensive services, such as prescription
drugs administered by a physician (Part B drugs; 99%), skilled
nursing facility stays (98%), and inpatient hospital stays (acute:
98%; psychiatric: 94%), but it is rarely required for preventive
services (6%).
- Federal spending on
Medicare Advantage bonus payments has increased every year since
2015 and will reach at least $10 billion in 2022. Payments vary
across firms, with UnitedHealthcare receiving the largest total
payments ($2.8 billion) and Kaiser Permanente receiving the highest
payment per enrollee ($521). (KFF is an independent, nonprofit
organization that analyzes national health issues and is not
affiliated with Kaiser Permanente.) Recently, the Medicare Payment
Advisory Commission (MedPAC) and others have raised questions about
whether the bonus program includes too many measures, does not
adequately account for social risk factors, and may not be a useful
indicator of quality for beneficiaries.
The full analyses are
available online and include:
(KFF has adjusted its
methodology from previous years to calculate the share of eligible
Medicare beneficiaries enrolled in Medicare Advantage, meaning they must
have both Part A and B coverage. This aligns with how the Medicare
Payment Advisory Commission (MedPAC) and others describe this population.
The share enrolled in Medicare Advantage would be somewhat smaller using
the old method. See the methods section of the analysis.)
For more data and analyses about Medicare Advantage, visit
kff.org
|
No comments:
Post a Comment